AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
DNA Diagnostics Market Size, Share & Trends by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Global Forecast to 2029
... 2029 The global DNA diagnostics market is valued at an estimated USD 13.3 billion in 2024 and is projected to reach USD 21.2 billion by 2029, at a CAGR of 9.7% during the forecast period. ... Read More
-
Anti-Viral Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Branded, Generics), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others) By Region and Competition, 2019-2029F
... Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others) By Region and Competition, 2019-2029F Global Anti Viral Drugs Market has valued at USD 76.01 billion in 2023 and is anticipated to project ... Read More
-
HIV/AIDS Testing
... at a CAGR of 6.1% over the analysis period 2023-2030. HIV/AIDS Testing Instruments, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$3.6 Billion by the end ... Read More
-
HIV Drugs
... at a CAGR of 5.3% over the analysis period 2023-2030. Combination HIV Medicines, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$29.0 Billion by the end ... Read More
-
United States Generic Drugs Market Report By Therapeutic Area (Epilepsy, Cancers, Heart Disease, Mental Health, Diabetes, Allergies & Asthama, Chronic Obstructive Pulmonary Diesase, Alzheimer's Disease, HIV/AIDS, Crohn's colitis), Type (Branded Generics, Unbranded Generics), Drug Delivery (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, Medicare D), States and Company analysis 2024-2032
... (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, ... Read More
-
Herpes Simplex Virus Infections
... reach US$6.6 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 6.6% CAGR The Herpes ... Read More
-
US Oral Antiviral Market Size study, by Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, Others) by Drug Class (Protease inhibitors, Reverse transcriptase inhibitors, Others) by Distribution Channel (Hospital pharmacies, Drug store and retail pharmacies, Online providers) Forecasts 2022-2032
... providers) Forecasts 2022-2032 US Oral Antiviral Market is valued approximately USD 9.98 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 1.69% over the forecast period 2024-2032. Oral ... Read More
-
Global Oral Antiviral Market Size study, by Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, Others) by Drug Class (Protease inhibitors, Reverse transcriptase inhibitors, Others) by Distribution Channel (Hospital pharmacies, Drug store and retail pharmacies, Online providers) and Regional Forecasts 2022-2032
... providers) and Regional Forecasts 2022-2032 Global Oral Antiviral Market is valued approximately USD 36.7 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 2.10% over the forecast period ... Read More
-
Sexually Transmitted Disease Diagnostics Market by Disease Type (Bacterial Vaginosis, Candidal Vaginitis, Chlamydia Trachomatis/ Neisseria Gonorrhoeae), Diagnostic methods (Antigen Detection, Molecular Diagnostics, Serologic Testing), Device Type, End-Use
... Diagnostics Market size was estimated at USD 106.53 billion in 2023 and expected to reach USD 112.56 billion in 2024, at a CAGR 5.97% to reach USD 159.97 billion by 2030. Sexually transmitted disease diagnostics ... Read More
-
Cytomegalovirus Treatment Market by Diseases (Encephalitis, Gastrointestinal Ulcers, Pneumonia), Drug (Cidofovir, Foscarnet, Ganciclovir), Distribution Channel, Application - Global Forecast 2024-2030
... to reach USD 576.99 million in 2024, at a CAGR 7.67% to reach USD 903.39 million by 2030. The cytomegalovirus (CMV) treatment includes all aspects of medical practices to manage and treat cytomegalovirus infections, a ... Read More
-
Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2024-2030
... 4.76 billion in 2023 and expected to reach USD 5.47 billion in 2024, at a CAGR 14.44% to reach USD 12.25 billion by 2030. Specialty drugs are normally complex to manufacture, high-cost medications requiring specialized ... Read More
-
Global anal fissure therapeutics market - 2024-2031
... period 2024-2031. An anorectal condition marked by inflammation or tearing of the lining of the lower rectum is known as an anal fissure. During bowel movements, it causes considerable discomfort and blood. The ailment is ... Read More
-
HIV Vaccines Market by Phase (Phase I, Phase II, Phase III), Category (Preventive Vaccines, Therapeutic Vaccines), Antibodies, End Users - Global Forecast 2024-2030
... 2023 and expected to reach USD 940.05 million in 2024, at a CAGR 12.88% to reach USD 1,951.26 million by 2030. The HIV vaccine pertains to the research, development, and commercialization of vaccines that are ... Read More
-
Gonorrhea – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Gonorrhea market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Gonorrhea market report provides current treatment practices, emerging drugs, Gonorrhea market share of the individual ... Read More
-
Sexually Transmitted Diseases Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... market size was valued at USD 9.52 billion in 2023 to USD 16.68 billion by 2030, exhibiting a CAGR of 8.3% during the forecast period of 2023-2030. Due to the reduction in number of reported ... Read More
-
HIV-associated Lipodystrophy – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the HIV-associated Lipodystrophy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The HIV-associated Lipodystrophy market report provides current treatment practices, emerging drugs, HIV-associated ... Read More
-
Trichomoniasis – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Trichomoniasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Trichomoniasis market report provides current treatment practices, emerging drugs, Trichomoniasis market share of the individual ... Read More
-
Syphilis – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Syphilis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Syphilis market report provides current treatment practices, emerging drugs, Syphilis market share of the individual ... Read More
-
Herpes Labialis – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Herpes Labialis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Herpes Labialis market report provides current treatment practices, emerging drugs, Herpes ... Read More
-
Kaposi's Sarcoma – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Kaposi's Sarcoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Kaposi's Sarcoma market report provides current treatment practices, emerging drugs, Kaposi's ... Read More
-
Herpes Simplex - Market Insight, Epidemiology And Market Forecast - 2034
... increase during the forecast period (2024–2034). Factors contributing to the rise of diagnosed prevalent cases of acne vulgaris include hormonal changes, dietary influences, genetic predisposition, and environmental factors such as pollution. In 2023, the market ... Read More
-
HPV-Induced Cancers – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the HPV-Induced Cancers market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The HPV-Induced Cancers market report provides current treatment practices, emerging drugs, HPV-Induced ... Read More
-
HPV-induced Cutaneous Tumors – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the HPV-induced Cutaneous Tumors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The HPV-induced Cutaneous Tumors market report provides current ... Read More
-
Recurrent Herpes Labialis – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Recurrent Herpes Labialis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Recurrent Herpes Labialis market report provides current ... Read More
-
Acquired Immunodeficiency Syndrome (AIDS) – Market Insight, Epidemiology, and Market Forecast – 2034
... Immunodeficiency Syndrome (AIDS), historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome (AIDS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Acquired Immunodeficiency Syndrome ... Read More
Research Assistance
